Psoriatic Arthritis Clinical Trials

53 recruiting

Psoriatic Arthritis Trials at a Glance

76 actively recruiting trials for psoriatic arthritis are listed on ClinicalTrialsFinder across 6 cities in 47 countries. The largest study group is Not Applicable with 14 trials, with the heaviest enrollment activity in Houston, Berlin, and Toronto. Lead sponsors running psoriatic arthritis studies include AbbVie, Takeda, and The Danish Center for Expertise in Rheumatology.

Browse psoriatic arthritis trials by phase

Treatments under study

About Psoriatic Arthritis Clinical Trials

Looking for clinical trials for Psoriatic Arthritis? There are currently 53 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Psoriatic Arthritis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Psoriatic Arthritis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 76 trials

Recruiting
Phase 1

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Hidradenitis SuppurativaPsoriatic ArthritisAxial Spondyloarthritis+1 more
UCB Biopharma SRL20 enrolled12 locationsNCT06888193
Recruiting
Not Applicable

Modifying PEST for Psoriatic Arthritis Screening

Psoriatic ArthritisPlaque Psoriasis
Novartis Pharmaceuticals502 enrolled21 locationsNCT06382051
Recruiting
Phase 3

A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis

Psoriatic ArthritisModerate to Severe Plaque Psoriasis
UCB Biopharma SRL90 enrolled16 locationsNCT06506916
Recruiting
Phase 1

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Psoriatic ArthritisAxial Spondyloarthritis
UCB Biopharma SRL392 enrolled42 locationsNCT07290036
Recruiting

APACHE Cohort (A Psoriatic Arthritis CoHort)

Psoriatic Arthritis (PsA)Cohort StudyRecent Peripheral Arthritis
Assistance Publique - Hôpitaux de Paris425 enrolled3 locationsNCT03768271
Recruiting

Oxidative Stress in Autoimmune Rheumatic Diseases

Psoriatic Arthritis (PsA)Ankylosing Spondylitis (AS)Rheumatoid Arthritis (RA)+1 more
University of Thessaly200 enrolled1 locationNCT07536529
Recruiting
Phase 2

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

Psoriatic Arthritis
Merck Sharp & Dohme LLC140 enrolled4 locationsNCT07486960
Recruiting
Phase 2

A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis

PsA (Psoriatic Arthritis)
InventisBio Co., Ltd222 enrolled1 locationNCT07315061
Recruiting
Phase 1

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Phase 2

A Study of SPY072 in Rheumatic Disease

Rheumatoid ArthritisPsoriatic ArthritisRheumatic Diseases+5 more
Spyre Therapeutics, Inc.285 enrolled57 locationsNCT07148414
Recruiting
Phase 3

Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis

Active Juvenile Psoriatic Arthritis
Amgen60 enrolled45 locationsNCT04804553
Recruiting
Phase 4

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo General Hospital477 enrolled2 locationsNCT07087912
Recruiting
Phase 3

A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

Juvenile Psoriatic Arthritis
Bristol-Myers Squibb60 enrolled47 locationsNCT06869551
Recruiting
Phase 3

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Psoriatic Arthritis
Takeda1,088 enrolled189 locationsNCT06671483
Recruiting
Phase 3

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

Psoriatic Arthritis
Takeda600 enrolled122 locationsNCT06671496
Recruiting
Phase 4

A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

Psoriatic ArthritisSpondyloarthritis, Axial
CARE ARTHRITIS LTD.100 enrolled5 locationsNCT06454188
Recruiting

Korean Post-marketing Surveillance for Xeljanz XR

Active Moderate to Severe Rheumatoid ArthritisActive Ankylosing SpondylitisActive Psoriatic Arthritis
Pfizer200 enrolled1 locationNCT04876781
Recruiting
Phase 2Phase 3

A Study of Picankibart in Patients With Active Psoriatic Arthritis

Psoriatic Arthritis
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.222 enrolled1 locationNCT07295509
Recruiting
Phase 4

Preventing Structural Damage in Early Psoriatic Arthritis

Psoriatic Arthritis (PsA)
Chinese University of Hong Kong108 enrolled1 locationNCT07486843
Recruiting
Phase 3

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

Psoriatic Arthritis
Takeda1,182 enrolled1 locationNCT07286058